KAI began, fittingly, with a conversation.
In 2018, David and Adam met at Coppa Club in Henley. Introduced by a mutual friend, they started exploring a simple but powerful idea: what if some of the most valuable insight in healthcare was already hidden inside everyday conversations?
Between pharmaceutical field teams and healthcare professionals. Between clinicians and patients. Between managers and teams. Between organisations and the people they serve.
These conversations shape trust, understanding, confidence, behaviour and outcomes. Yet for most organisations, the insight inside them remains invisible, trapped between the two people in the room.
KAI was born from the belief that this needed to change.
Across healthcare and life sciences, organisations were making major decisions on incomplete evidence.
Field feedback was anecdotal. Market research was slow. Coaching was inconsistent. Quality assurance relied on small samples and manual review. Training was generic, expensive, and disconnected from real customer behaviour.
The opportunity was clear. If conversations could be analysed responsibly and intelligently, they could become an organisational asset, not as surveillance, not as recording for the sake of recording, but as a way to help people improve, help teams learn faster, and help healthcare organisations make better decisions.
AI was the obvious answer. But not in the way many people were using it.
Early conversation analytics focused on surface-level signals: keywords, talk time, simple sentiment, dashboards full of clever but unactionable outputs. Too many squiggly lines. Not enough meaning.
KAI was built around a different belief: conversation intelligence only matters if it helps people understand what happened, why it mattered, and what to do next.
That meant going beyond transcription to understand context, confidence, sentiment, message delivery, customer reaction, behaviour change, and the quality of connection between people.
From the start, KAI's ambition wasn't just to analyse conversations. It was to reveal the hidden human insight inside them.
"The future is already here, it's just not evenly distributed." - William Gibson
One of KAI's founding frustrations was that so much AI capability sat in the hands of a few large technology companies. But the organisations that could benefit most from better human conversations; healthcare providers, pharmaceutical teams, patient-facing organisations didn't always have access to practical, usable AI.
KAI's mission became simple:
Reveal hidden human insight that enables better conversations and improved commercial outcomes.
Today, conversation intelligence for life sciences is becoming a recognised category.
KAI was building in this space before the category was fashionable. The timeline tells the story:
2018: The idea behind KAI began.
2019: KAI was formally founded.
2020: KAI deployed its MVP in pharma, combining acoustic, language and visual AI.
2021: Fine-tuning models for pharma therapies, applications and emotional intelligence.
2022–23: Multilingual capability built; projects with top pharma organisations across all continents where pharma teams operate.
2024: Launch of NetKonnector™, AI Personal Coach, and the KAI app.
2025: First Full Enterprise - Global roll-outs across Top 10 Pharma.
2026: ....
Conversation intelligence in healthcare cannot be built in theory. It has to be learned through real deployments - real conversations, real markets, real languages, real therapy areas, real enterprise requirements.
That's what this timeline represents.
When COVID changed the world, it also changed the way healthcare communicated.
Pharma field teams moved to remote engagement. Clinicians moved to virtual consultations. Teams began relying on Zoom, Teams and other digital channels almost overnight. Suddenly, high-value healthcare conversations were happening in digital formats that could be analysed, understood and improved.
For KAI, this accelerated the opportunity, and helped us develop models that worked in real healthcare environments. Not generic conversation analytics. Healthcare conversation intelligence.
As KAI analysed more conversations, one pattern became clear.
The most valuable insight wasn't only in the words. It was in the human connection.
Did the healthcare professional lean in or pull away? Did the patient feel understood? Did confidence increase or decrease? Did a rep simply deliver a message, or did they create a belief shift? Did the conversation lead to action, or just information exchange?
KAI began working with psychologists and behavioural experts to understand the patterns that lead to connection, disconnection, trust, confidence and change.
This evolved into one of KAI's most important differentiators: the ability to analyse conversations through an emotional intelligence lens. KAI's platform helps people and organisations understand not just what was said, but what was felt, understood and acted upon.
Pharma AI doesn't deploy through marketing. It deploys through trust and through partners.
KAI now operates the largest partner network in Pharma conversation intelligence: integrators, consultancies, regional specialists and platform partners who deliver KAI inside enterprise environments around the world.
That ecosystem isn't something a company can build in a year, or in two. It is built deployment by deployment, market by market, relationship by relationship. It is one of the clearest indicators of where experience genuinely sits in this category.
KAI is now a conversation intelligence platform for life sciences, helping Pharma decision-makers drive stronger field force impact, sharper customer insights and accelerated brand performance.
The platform supports Launch teams, Marketing team, Commercial teams, Medical teams, Market Access, Consumer and Healthcare organisations across three core areas:
Marketing and launch intelligence: Turning real conversations into customer, brand and therapy-area intelligence for brand and leadership teams.
Salesforce effectiveness: Helping commercial teams understand where field teams are creating connection, communicating value, handling objections, uncovering needs and moving conversations toward meaningful outcomes.
Learning and development: Helping managers and coaches move beyond generic training by identifying real strengths, skill gaps and coaching opportunities from actual conversations.
KAI has now analysed more than 50,000 conversations, across 98+ languages and over 15+ therapy areas, generating more than 200,000 data points per conversation across every continent where our clients operate.
These aren't marketing statistics. They represent years of model refinement, deployment experience, and learning about what global Pharma teams actually need.
In Pharma AI, it is easy to make bold claims. It is harder to build technology that enterprise organisations can depend on.
The challenge is not analysing a transcript. It is doing it accurately, consistently and responsibly across global organisations. It is earning trust from compliance, legal, IT, medical, commercial and field leadership from the people whose conversations are being analysed. It is creating insight useful enough to actually change behaviour. It is helping organisations move from anecdote to evidence.
That is where experience matters.
KAI's platform has been shaped by real-world deployment from the beginning: pharma pilots, global projects, healthcare programmes, multilingual analysis, therapy-area tuning, emotional intelligence modelling, coaching frameworks, enterprise app development and partner-led implementation.
KAI's story has always been about more than technology. It is about helping people understand each other better.
Helping launch teams succeed in the first 6 months, field teams engage HCPs more effectively. Helping medical teams surface richer insight. Helping managers coach with evidence. Helping brands understand what customers really think and feel. Helping healthcare organisations improve the quality of patient and clinician conversations.
From an idea in 2018, to formal founding in 2019, to pharma deployment in 2020, through multilingual global projects, to NetKonnector®, AI Personal Coach and today's enterprise platform, KAI has been building the future of healthcare conversation intelligence for years.
The timeline is the argument.
Better conversations. Better outcomes.